Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leisa Johnson

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cold Spring Harbor Protocols|September 4, 2014
Genetically engineered knock-in and conditional knock-in mouse models of cancerAmy Rappaport, Leisa Johnson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Using genetically engineered mouse models of cancer to aid drug development: an industry perspectiveMallika Singh, Leisa Johnson
Cancer Research|May 18, 2012
Genetically engineered mouse models: closing the gap between preclinical data and trial outcomesMallika Singh, Christopher L Murriel, Leisa Johnson
Nature|October 24, 2008
Generation of a prostate from a single adult stem cellKevin G Leong, Bu-Er Wang, Leisa Johnson, et al.
Genes & Cancer|May 23, 2015
Requirement for BUB1B/BUBR1 in tumor progression of lung adenocarcinomaHonglin Chen, James Lee, Noelyn M Kljavin, et al.
Cancer Cell|June 28, 2002
Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agentsLeisa Johnson, Annie Shen, Larry Boyle, et al.
Cancer Research|October 30, 2003
A prodrug strategy using ONYX-015-based replicating adenoviruses to deliver rabbit carboxylesterase to tumor cells for conversion of CPT-11 to SN-38Hilde Stubdal, Noah Perin, Marilyn Lemmon, et al.
Cancer & Metabolism|November 8, 2014
Metabolic and transcriptional profiling reveals pyruvate dehydrogenase kinase 4 as a mediator of epithelial-mesenchymal transition and drug resistance in tumor cellsYuting Sun, Anneleen Daemen, Georgia Hatzivassiliou, et al.
Cancer Cell|December 9, 2008
Distinct thresholds govern Myc's biological output in vivoDaniel J Murphy, Melissa R Junttila, Laurent Pouyet, et al.
Cancer Research|November 24, 2011
Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapyYuting Sun, Bu-Er Wang, Kevin G Leong, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cold Spring Harbor Protocols|September 4, 2014
Genetically engineered knock-in and conditional knock-in mouse models of cancerAmy Rappaport, Leisa Johnson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Using genetically engineered mouse models of cancer to aid drug development: an industry perspectiveMallika Singh, Leisa Johnson
Cancer Research|May 18, 2012
Genetically engineered mouse models: closing the gap between preclinical data and trial outcomesMallika Singh, Christopher L Murriel, Leisa Johnson
Nature|October 24, 2008
Generation of a prostate from a single adult stem cellKevin G Leong, Bu-Er Wang, Leisa Johnson, et al.
Genes & Cancer|May 23, 2015
Requirement for BUB1B/BUBR1 in tumor progression of lung adenocarcinomaHonglin Chen, James Lee, Noelyn M Kljavin, et al.
Cancer Cell|June 28, 2002
Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agentsLeisa Johnson, Annie Shen, Larry Boyle, et al.
Cancer Research|October 30, 2003
A prodrug strategy using ONYX-015-based replicating adenoviruses to deliver rabbit carboxylesterase to tumor cells for conversion of CPT-11 to SN-38Hilde Stubdal, Noah Perin, Marilyn Lemmon, et al.
Cancer & Metabolism|November 8, 2014
Metabolic and transcriptional profiling reveals pyruvate dehydrogenase kinase 4 as a mediator of epithelial-mesenchymal transition and drug resistance in tumor cellsYuting Sun, Anneleen Daemen, Georgia Hatzivassiliou, et al.
Cancer Cell|December 9, 2008
Distinct thresholds govern Myc's biological output in vivoDaniel J Murphy, Melissa R Junttila, Laurent Pouyet, et al.
Cancer Research|November 24, 2011
Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapyYuting Sun, Bu-Er Wang, Kevin G Leong, et al.
Pageof 2